News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BoXin LaiTe Biotechnology and University of British Columbia Sign MOU


6/18/2013 12:41:14 PM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 18, 2013 -- Sichuan BoXin LaiTe Biotechnology and its major shareholder, Heracles International Investment Inc. have signed a memorandum of understanding to form a partnership with the Center for Blood Research (CBR) at the University of British Columbia. BoXin LaiTe and Heracles use their ability to validate the commercial and clinical of novel discoveries made at the CBR and accelerate their development for the China market. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES